METHOD OF INDUCING KIDNEY FROM PLURIPOTENT STEM CELLS
    7.
    发明公开
    METHOD OF INDUCING KIDNEY FROM PLURIPOTENT STEM CELLS 审中-公开
    VERFAHREN ZUR NIERENINDUZIERUNG AUS PLURPOTENTEN STAMMZELLEN

    公开(公告)号:EP3059308A4

    公开(公告)日:2017-03-22

    申请号:EP14853879

    申请日:2014-10-16

    IPC分类号: C12N5/10 C12N5/071 C12N5/0735

    摘要: The purpose of the present invention is to provide a process or method that can be utilized when deriving a three-dimensional structure of a kidney from pluripotent stem cells such as ES cells or iPS cells. The differentiation inducing method is characterized by culturing pluripotent cells with the following three steps, in order: (a) a step of culturing an embryoid body induced from the pluripotent stem cells in medium containing Bmp4 and a high-concentration (concentration A) Wnt agonist; (b) a step of culturing the embryoid body in medium which contains activin, Bmp4, retinoic acid and a middle-concentration (concentration B) Wnt agonist; and (c) a step of culturing the embryoid body in medium containing Fgf9 and a low-concentration (concentration C) Wnt agonist (herein, the Wnt agonist concentrations is concentration A > concentration B > concentration C).

    摘要翻译: 本发明的目的是提供当从多能干细胞(例如ES细胞或iPS细胞)衍生肾的三维结构时可以使用的方法或方法。 分化诱导方法的特征在于以下三个步骤培养多能细胞:(a)在含有Bmp4和高浓度(浓度A)Wnt激动剂的培养基中培养由多能干细胞诱导的胚状体的步骤 ; (b)在含有激活素,Bmp4,视黄酸和中浓度(浓度B)Wnt激动剂的培养基中培养类胚体的步骤; 和(c)在含有Fgf9和低浓度(C浓度)Wnt激动剂的培养基中培养胚状体的步骤(Wnt激动剂浓度为浓度A>浓度B>浓度C)。

    IMPROVEMENTS IN OR RELATING TO GROWING CELLS
    8.
    发明授权
    IMPROVEMENTS IN OR RELATING TO GROWING CELLS 有权
    的改进,因此ZUSAMMENHENGEND细胞的生长

    公开(公告)号:EP2376627B1

    公开(公告)日:2017-03-15

    申请号:EP09795527.2

    申请日:2009-12-16

    申请人: UCL Business PLC

    IPC分类号: A61M1/34 A61K35/12 C12N5/071

    摘要: The present invention relates to a method of growing a plurality of cells (110) to performance competence in a matrix forming agent (120) containing one or more density modifiers (130), characterized in that the cells are grown in a culture media supplemented with from 2-20% human plasma. It also relates to a biological component (100) comprising: i. a matrix forming agent (120), ii. a plurality of cells (110), and iii. one or more density modifiers (130), wherein at performance competence, the cells are present in the matrix forming agent at a density of at least 3×107 cells/ml.

    MATRIX AND IMPLANT FOR TISSUE ENGINEERING
    10.
    发明公开
    MATRIX AND IMPLANT FOR TISSUE ENGINEERING 审中-公开
    MATRIX UND IMPLANTAT祖尔GEWEBEZÜCHTUNG

    公开(公告)号:EP3010556A1

    公开(公告)日:2016-04-27

    申请号:EP14731159.1

    申请日:2014-06-16

    申请人: Baer, Hans U.

    发明人: Baer, Hans U.

    摘要: The present invention relates to a porous matrix for tissue engineering comprising a first biodegradable and biocompatible polymer component forming a three-dimensional primary structure with primary pores, and further comprising a second biodegradable and biocompatible polymer component other than the first polymer component selected from the group consisting of collagens, laminin, fibronectin and mixtures thereof, wherein the second polymer component forms a three-dimensional secondary structure which is contained within the interior space of at least a part of the primary pores.

    摘要翻译: 本发明涉及用于组织工程的多孔基质,其包含形成具有初级孔的三维一级结构的第一种可生物降解和生物相容的聚合物组分,并且还包含第二种可生物降解和生物相容的聚合物组分, 由胶原,层粘连蛋白,纤连蛋白及其混合物组成,其中第二聚合物组分形成三维二级结构,其包含在至少一部分初级孔的内部空间内。